New surgical and non-surgical options to preserve corneal function.
The Vanderbilt Eye Institute team is excited to share our insights at this year's gathering of the American Academy of Ophthalmology®.
Small molecule compounds to promote intrinsic, regenerative responses in vivo.
New techniques are eradicating cancer and preserving vision for retinoblastoma, uveal melanoma.
Two pioneering technologies may help predict vision loss from retinopathies.
Can eye screening through PCPs change the paradigm for blindness prevention?
1 / 5
PEDIG study will test partial prism correction for controlling eye deviation.
Research confirms central retinal artery occlusion brings undiagnosed risk factors for cardiovascular and cerebrovascular events.
Through a global health grant, Vanderbilt will help bring eye care to survivors.